ADAD (Huaizhong Health Group) Current Deferred Revenue: $0.00 Mil (As of Jan. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADAD Huaizhong Health Group Inc ADAD
34 GF Score
Price $0.00
View Full Analysis

What is Huaizhong Health Group Current Deferred Revenue?

Huaizhong Health Group ADAD 34 Current Deferred Revenue is $0.00 Mil as of Jan. 2023. GuruFocus rates ADAD with a GF Score™ of 34/100.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Huaizhong Health Group's current deferred revenue for the quarter that ended in Jan. 2023 was $0.00 Mil.

Huaizhong Health Group Current Deferred Revenue Related Terms

Huaizhong Health Group Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Huaizhong Health Group's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Huaizhong Health Group Current Deferred Revenue Chart

Huaizhong Health Group Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Huaizhong Health Group Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ADAD
34GF Score
Huaizhong Health Group Inc ADAD
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of $0.00 Mil mean?
Huaizhong Health Group (ADAD) has a Current Deferred Revenue of $0.00 Mil as of Jan. 2023. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Huaizhong Health Group and its competitors.
Is Huaizhong Health Group's Current Deferred Revenue too high?
Huaizhong Health Group's current Current Deferred Revenue is $0.00 Mil. Overall, Huaizhong Health Group has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Huaizhong Health Group's Current Deferred Revenue compare to AMRR and NLSC?
Huaizhong Health Group's Current Deferred Revenue of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Diversified Financial Services company?
A good Current Deferred Revenue depends on the Diversified Financial Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Huaizhong Health Group and its competitors. Huaizhong Health Group's current Current Deferred Revenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huaizhong Health Group stock overvalued right now?
Huaizhong Health Group (ADAD) has a current Current Deferred Revenue of $0.00 Mil. The current Current Deferred Revenue is $0.00 Mil. Huaizhong Health Group's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Huaizhong Health Group (ADAD), the current Current Deferred Revenue is $0.00 Mil as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Huaizhong Health Group Business Description

Address 555 Panyu North Avenue, 13th Floor, Headquarters Center Building 16, Tianan Technology Park, Panyu District, Guangzhou, CHN, 523857
Huaizhong Health Group Inc is a shell company. It is, however, seeking to identify, locate, and, if warranted, acquire new commercial opportunities.
34GF Score

Get the complete analysis for ADAD

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price